Prospective Evaluation
of Aortic Valve Replacement in Young Adults and Middle-aged Patients:
Mechanical Prosthesis versus Pulmonary Autograft
Manuel Concha, Pedro J. Aranda, Jaime Casares, Carlos Merino, Pedro
Alados, Ignacio Muñoz, Rafael Villalba, Javier Ariza
Cardiovascular Surgery Department, Regional
Tissue Bank, Cardiology Department, Hospital Universitario Reina
Sofía, Córdoba, Spain |
Background and aim of the study: The best option
for aortic valve replacement (AVR) in young adults and middle-aged patients
remains controversial. A longitudinal comparison between the Ross procedure
(RP) and mechanical prosthesis (MP) was conducted in this group of patients.
Methods: Between January 1997 and January 2003, 125 consecutive
patients (age range: 20-50 years) were submitted for AVR; 62 patients
(mean age 37.73 ± 7.28 years) were included in the MP group,
and 63 (mean age 35.33 ± 7.63 years) in the RP group. Gender,
etiology, NYHA functional class and other preoperative data were
comparable between the two groups.
Results: The operative mortality was four (6.5%) in the
MP group, and one (1.6%) in the RP group (p = NS). The postoperative
complication rate was similar in both groups. Two RO patients required
early autograft replacement due to severe regurgitation. There
were no late deaths during the follow up period. In the MP group,
three patients (4.8%) suffered |
major bleeding, three (4.8%) were diagnosed with prosthetic
endocarditis (one required reoperation), and three (4.8%) suffered valve-
or coumarin-related thromboembolic complications. All RP patients were
free from bleeding, thromboembolic, or infectious complications, but
three suffered severe pulmonary homograft stenosis (one re-replacement,
one Palmaz stent, and one under clinical surveillance). The combined
freedom from death or major complications was 64.72 ± 4.3% in
the MP group, and 87.92 ± 9.65% in the RP group (p = 0.068).
Conclusion: Intraoperative and early postoperative morbidity
and mortality rates were similar among RP and MP patients, despite
a steep learning curve during the early RP cases. Although the
follow up was limited, and homograft-related morbidity was seen
in the RP group, the overall five-year major complication rate
supported use of the pulmonary autograft for AVR in patients aged
between 20 and 50 years.
The Journal of Heart Valve Disease 2005;14:40-46 |